Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0470
-0.0010 (-2.08%)
Oct 1, 2026, 3:50 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 56.82 million as of October 1, 2026. Its market cap has decreased by -48.41% in one year.
Market Cap
56.82M
Enterprise Value
42.46M
Revenue
3.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 56.82M, an increase of 221.45%. That is a compound annual growth rate of 4.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 56.82M | -49.14% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 108.01M |
| Recce Pharmaceuticals | 94.79M |
| Alterity Therapeutics | 90.49M |
| LTR Pharma | 85.44M |
| Avecho Biotechnology | 73.41M |
| Prescient Therapeutics | 70.45M |
| Entropy Neurodynamics | 64.53M |
| Neurizon Therapeutics | 60.46M |